Fig. 2From: No clinically significant pharmacokinetic interactions between dolutegravir and daclatasvir in healthy adult subjectsMean plasma concentration-time profiles of daclatasvir (DCV) administered with and without dolutegravir (DTG). Abbreviations: q24h, every 24 h; SD, standard deviationBack to article page